The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

Novo Nordisk’s NVO shares lost 5.3% on Friday after Medicare issued a press release selecting the company’s popular ...

Novo Nordisk has faced a massive selloff in recent months amid disappointing drug trials and U.S. pressure to cut its prices.

CHARLOTTESVILLE, Va. (WVIR) - Weight loss and diabetes drugs such as Ozempic and Wegovy could possibly be covered by Medicare ...